{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:46:04Z","timestamp":1760298364470,"version":"3.38.0"},"reference-count":57,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1421,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1476-5381.2011.01520.x","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T13:49:46Z","timestamp":1307454586000},"page":"1558-1572","source":"Crossref","is-referenced-by-count":11,"title":["Involvement of the first transmembrane segment of human \u03b12-adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine"],"prefix":"10.1111","volume":"164","author":[{"given":"JMM","family":"Laurila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Wissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Xhaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JO","family":"Ruuskanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MS","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Scheinin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/mol.56.1.154","article-title":"Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice","volume":"56","author":"Altman","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume-title":"Receptor Molecular Biology","author":"Ballesteros","year":"1995"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/jm049612a","article-title":"Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes","volume":"48","author":"Boeckler","year":"2005","journal-title":"J Med Chem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08650","article-title":"Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor","volume":"463","author":"Bokoch","year":"2010","journal-title":"Nature"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"7","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/01.CIR.0000036600.39600.66","article-title":"Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure","volume":"106","author":"Brede","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.1150577","article-title":"High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor","volume":"318","author":"Cherezov","year":"2007","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1046\/j.1471-4159.2000.0741705.x","article-title":"Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304","volume":"74","author":"Cockcroft","year":"2000","journal-title":"J Neurochem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0022-3565(25)20772-8","article-title":"Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes","volume":"278","author":"Deupree","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1073\/pnas.91.23.11178","article-title":"The palmitoylated cysteine of the cytoplasmic tail of alpha 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation","volume":"91","author":"Eason","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"31279","DOI":"10.1074\/jbc.M104167200","article-title":"Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors","volume":"276","author":"Frang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0167-4889(95)90410-I","article-title":"Recombinant human alpha 2-adrenoceptor subtypes: comparison of [3H]rauwolscine, [3H]atipamezole and [3H]RX821002 as radioligands","volume":"1266","author":"Halme","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2008.05.001","article-title":"A specific cholesterol binding site is established by the 2.8 \u00c5 structure of the human beta2-adrenergic receptor","volume":"16","author":"Hanson","year":"2008","journal-title":"Structure"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB16|cit15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0028-3908(95)00018-2","article-title":"Adrenergic receptor signal transduction and regulation","volume":"34","author":"Hein","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB15|cit16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/46040","article-title":"Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission","volume":"402","author":"Hein","year":"1999","journal-title":"Nature"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1164772","article-title":"The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist","volume":"322","author":"Jaakola","year":"2008","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1006\/jmbi.1993.1548","article-title":"A structural basis for sequence comparisons. An evaluation of scoring methodologies","volume":"233","author":"Johnson","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/sj.bjp.0707330","article-title":"The second extracellular loop of alpha2A-adrenoceptors contributes to the binding of yohimbine analogues","volume":"151","author":"Laurila","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.273.5276.803","article-title":"Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c","volume":"273","author":"Link","year":"1996","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB23|cit22","first-page":"241","article-title":"Distribution and pharmacology of alpha2-adrenoceptors in the central nervous system","volume":"46","author":"MacDonald","year":"1995","journal-title":"J Physiol Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB22|cit23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-6147(97)90625-8","article-title":"Gene targeting - homing in on alpha2-adrenoceptor-subtype function","volume":"18","author":"MacDonald","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.273.5276.801","article-title":"Central hypotensive effects of the alpha2a-adrenergic receptor subtype","volume":"273","author":"MacMillan","year":"1996","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s100240010138","article-title":"Distribution of alpha2-adrenergic receptor binding in the developing human brain stem","volume":"4","author":"Mansouri","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"21867","DOI":"10.1074\/jbc.274.31.21867","article-title":"Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human alpha(2A)-adrenergic receptor","volume":"274","author":"Marjam\u00e4ki","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrd2877","article-title":"Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008","volume":"8","author":"Michino","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.289.5480.739","article-title":"Crystal structure of rhodopsin: a G protein-coupled receptor","volume":"289","author":"Palczewski","year":"2000","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjp.0705439","article-title":"Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor","volume":"140","author":"Peltonen","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(97)01154-0","article-title":"Alpha2-adrenoceptor regulation of adenylyl cyclase in CHO cells: Dependence on receptor density, receptor subtype and current activity of adenylyl cyclase","volume":"335","author":"Pohjanoksa","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"28318","DOI":"10.1074\/jbc.271.45.28318","article-title":"Activation of the alpha1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint","volume":"271","author":"Porter","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2105-7-167","article-title":"Prediction of indirect interactions in proteins","volume":"7","author":"Prusis","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0896-6273(92)90034-B","article-title":"Constitutively active mutants of rhodopsin","volume":"4","author":"Robinson","year":"1992","journal-title":"Neuron"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1126\/science.1150609","article-title":"GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function","volume":"318","author":"Rosenbaum","year":"2007","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(94)90058-2","article-title":"Alpha-adrenoceptors","volume":"61","author":"Ruffolo","year":"1994","journal-title":"Pharmacol Ther"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB37|cit36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/molbev\/msg224","article-title":"Identification of duplicated fourth alpha2-adrenergic receptor subtype by cloning and mapping of five receptor genes in zebrafish","volume":"21","author":"Ruuskanen","year":"2004","journal-title":"Mol Biol Evol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB36|cit37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjp.0706057","article-title":"Conserved structural, pharmacological and functional properties among the three human and five zebrafish alpha 2-adrenoceptors","volume":"144","author":"Ruuskanen","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0163-7258(99)00032-7","article-title":"Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues","volume":"84","author":"Saunders","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0169-328X(94)90386-7","article-title":"Distribution of alpha2-adrenergic receptor subtype gene expression in rat brain","volume":"21","author":"Scheinin","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1021\/bi011204a","article-title":"The first transmembrane segment of the dopamine D2 receptor: Accessibility in the binding-site crevice and position in the transmembrane bundle","volume":"40","author":"Shi","year":"2001","journal-title":"Biochemistry"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB43|cit42","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1073\/pnas.84.13.4384","article-title":"Identification of residues required for ligand binding to the beta-adrenergic receptor","volume":"84","author":"Strader","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB42|cit43","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1016\/S0021-9258(18)80035-7","article-title":"Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor","volume":"264","author":"Strader","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/jpet.107.129601","article-title":"Pharmacological profile of histaprodifens at four recombinant histamine H1 receptor species isoforms","volume":"324","author":"Strasser","year":"2008a","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1124\/jpet.108.140913","article-title":"Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor","volume":"326","author":"Strasser","year":"2008b","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/prot.20768","article-title":"A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors","volume":"62","author":"Surgand","year":"2006","journal-title":"Proteins"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"15488","DOI":"10.1016\/S0021-9258(18)98642-4","article-title":"A point mutation in the seventh hydrophobic domain of the alpha 2-adrenergic receptor increases its affinity for a family of beta receptor antagonists","volume":"266","author":"Suryanarayana","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(97)01521-5","article-title":"[3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine","volume":"343","author":"Uhl\u00e9n","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/ci800315d","article-title":"ShaEP: molecular overlay based on shape and electrostatic potential","volume":"49","author":"Vainio","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0026-895X(25)12922-2","article-title":"Site-directed mutagenesis of alpha2A-adrenergic receptors: Identification of amino acids involved in ligand binding and receptor activation by agonists","volume":"40","author":"Wang","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature07101","article-title":"Structure of a beta1-adrenergic G-protein-coupled receptor","volume":"454","author":"Warne","year":"2008","journal-title":"Nature"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.sbi.2008.09.010","article-title":"Structural insights into G-protein-coupled receptor activation","volume":"18","author":"Weis","year":"2008","journal-title":"Curr Opin Struct Biol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.109.055384","article-title":"Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor","volume":"76","author":"Wittmann","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/mol.54.6.1088","article-title":"Chimeric receptor analysis of the ketanserin binding site in the human 5-hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding","volume":"56","author":"Wurch","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jsb.2004.12.008","article-title":"Model structures of alpha-2 adrenoceptors in complex with automatically docked antagonist ligands raise the possibility of interactions dissimilar from agonist ligands","volume":"150","author":"Xhaard","year":"2005","journal-title":"J Struct Biol"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1021\/jm0511031","article-title":"Molecular evolution of adrenoceptors and dopamine receptors: Implications for the binding of catecholamines","volume":"49","author":"Xhaard","year":"2006","journal-title":"J Med Chem"},{"key":"10.1111\/j.1476-5381.2011.01520.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0026-895X(25)09540-9","article-title":"Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding","volume":"50","author":"Zhao","year":"1996","journal-title":"Mol Pharmacol"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2011.01520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1476-5381.2011.01520.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:48:00Z","timestamp":1741222080000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2011.01520.x"}},"subtitle":["TM1 impacts the ligand binding of \u03b12-adrenoceptors"],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01520.x","relation":{},"ISSN":["0007-1188"],"issn-type":[{"type":"print","value":"0007-1188"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}